Tissue Engineering Market Size Worth $29.65Bn, Globally, by 2028 at 12.2% CAGR - Exclusive Report by The Insight Partners

NEW YORK, May 19, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Tissue Engineering Market Forecast to 2028 – COVID-19 Impact and Global Analysis - By Material Type (Synthetic Material, Biologically Derived Materials, and Others) and Application (Orthopedic, Musculoskeletal & Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, Urology, GI & Gynecology, Cancer, and Others)", the global tissue engineering market is expected to reach $13.23 billion in 2022 and is projected to touch $29.65 billion by 2028; it is expected to grow at a CAGR of 12.2% from 2022 to 2028.

The Sample Pages Showcases Content Structure and Nature of Information Included in This Research Study Which Presents A Qualitative and Quantitative Analysis: https://www.theinsightpartners.com/sample/TIPRE00006702/

The tissue engineering market growth is driven by the increased incidences of chronic diseases, road accidents, and trauma injuries and technological advancements in the field of 3D tissue engineering. However, the high cost of treatments related to tissue engineering is hindering the global market. The biologically derived materials segment dominated the global market and held the largest market share of 52.54% in 2022. The orthopedic, musculoskeletal & spine segment dominated the global market and held the largest market share of 34.31% in 2022.

Global Tissue Engineering Market: Competitive Landscape and Key Developments

Stryker Corporation, Organogenesis Inc., Cook Biotech Inc., Integra Life Sciences Corporation, 3M, AbbVie, Inc., Medtronic, Zimmer Biomet, Baxter International Inc., DePuy Synthes (Johnson & Johnson Services, Inc.), and B. Braun Melsungen AG implemented various organic strategies, such as partnerships and collaborations, which bought dynamic improvements in the global tissue engineering market. Various companies are also adopting organic strategies, such as product launches and expansions, to expand their business and enhance their geographic presence. Additionally, product launch and expansion help market players strengthen their customer base and expand the product portfolio.

Schedule A Pre-Sale Discussion with The Author Team in A Slot That You Prefer to Address Queries on Scope of The Study, Customization, Introduction to Research Methodology, Assistance on Technologies and Market Definitions: https://www.theinsightpartners.com/inquiry/TIPRE00006702/

In April 2022, Organogenesis announced that the latest advanced wound care research on its PuraPly AM, Affinity, Apligraf, NuShield, Novachor, and Organogenesis Physician Solutions product lines would be showcased at the 2022 Symposium on Advanced Wound Care (SAWC) Spring Conference, held between April 6 and April 10, 2022, in Phoenix, Arizona.

In December 2021, Baxter International Inc. completed its acquisition of Hillrom. Baxter paid US$ 156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of US$ 10.5 billion (based on Hillrom share counts at closing).

In November 2021, Stryker announced that it completed the previously announced acquisition of Wright Medical Group N.V., a global medical device company focused on extremities and biologics.

In July 2021, Integra LifeSciences Holding Corporation announced positive clinical outcomes for PriMatrix Dermal Repair Scaffold to manage hard-to-heal diabetic foot ulcers (DFUs).

In May 2021, Allergan Aesthetics, a part of AbbVie, announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Acoustic Pulse device, which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance. It is a non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition of Soliton expands and complements Allergan Aesthetics' Body Contouring treatment portfolio, which includes CoolSculpting Elite.

Click Here to Avail Lucrative DISCOUNTS on Our Latest Research Reports. We Offer Student, Enterprise, and Special Periodic Discounts to Our Clientele. Please Fill the Form to Know DISCOUNTED PRICE

In July 2020, Integra LifeSciences Holding Corporation announced its SurgiMend Collagen Matrix for Soft Tissue Reconstruction had received an Innovative Technology contract from Vizient, Inc., the nation's largest member-driven healthcare performance improvement company. The contract was awarded based on the recommendation by hospital experts who serve on one of Vizient's member-led councils.

Global Tissue Engineering Market: Key Insights – Future Trends

Tissue engineering and regenerative medicine have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, tissue engineering and regenerative medicine (TERM) are still in their infancy. Many fundamental questions remain to be answered, including the selection of cell sources, the development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues, such as blood vessels, nerve tissue, skin, and bones. Several techniques should be developed for stem cell engineering involving new materials, new structures, and novel surface modifications of biomaterials; a deeper understanding of the interactions between cells and biomaterials is needed.

Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles.

Have A 15-Minute-Long Discussion with The Lead Research Analyst and Author of The Report in A Time Slot Decided by You. You Will Be Briefed About the Contents of The Report and Queries Regarding the Scope of The Document Will Be Addressed as Well: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006702

Rapid advancements in the development of regenerative medicines to provide more effective solutions for chronic conditions are driving the global tissue engineering market's growth. Cell therapy is one of the fastest-growing segments of the regenerative medicines domain. Novartis's Kymriah was the first cell therapy solution offered to treat B-cell acute leukemia, which opened opportunities for this emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products, RCH-01, RCS-01, and RCT-01, in the development phase.

Further, Sernova is engaged in developing regenerative medicine technologies and has a huge pipeline of products for conditions, such as Diabetes, Hemophilia A, and hyperthyroidism. Therefore, due to these advancements, the market for tissue engineering is expected to rise significantly in the near future.

Global Tissue Engineering Market: Segmental Overview

Based on material type, the global tissue engineering market is segmented into synthetic material, biologically derived materials, and others. The biologically derived materials segment is expected to hold the largest share of the market in 2022. In contrast, the synthetic material segment is anticipated to register the highest CAGR of 12.9% in the market during the forecast period. Synthetic polymers are basic biomaterials, namely polyanhydrides and naturally occurring polymers, such as complex sugars (hyaluronan & chitosan) and other inorganics (hydroxyapatite). These materials are classified based on functions, such as injectables, hydrogels, surface modified, capable of drug delivery, and other specific features.

Immediate Delivery of Our Off-The-Shelf Reports and Latest Research Studies, Through Flexible and Convenient Payment Methods: https://www.theinsightpartners.com/buy/TIPRE00006702/

Also, a non-viable biomaterial, called filler, is used in medicinal products as part of a complex human or veterinary medicine system to control the interactions with components of living systems. A biomaterial plays a significant role in the development of tissue engineering and biomedical devices that naturally increase the regenerative potential of tissues to restore body mechanisms in a state of deterioration. Owing to the benefits offered by biomaterials while rectifying malfunctioning, tissue injury, or disease and aging, demand for these derivatives is expected to increase during the forecast period.

Browse Adjoining Reports:

Biomedical Materials Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial, Natural Biomaterial); Application (Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Neurology, Others); End user (Healthcare facilities, Diagnostic centres, Tissue engineering, Others) and Geography

3D Bio printing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (Organ Transplantation, Tissue Engineering); Technology (Inkjet Based, Laser Based, Extrusion Based, Magnetic); Application (Clinical Application, Research Application)

Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Lysogeny Broth, Serum-Free Media, Specialty Media, Classical Media, Stem Cell Media, Chemically Defined Media, Others); Application (Biopharmaceuticals, Biological Drug Discovery, Cancer Research, Tissue Engineering, Stem Cell Technologies, Other Applications); End User (Academic Institute, Research and Development Laboratory, Biotechnology Industry, Other End Users) and Geography

Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

Biomaterials Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( Natural Biomaterials, Polymers Biomaterials, Ceramic Biomaterials, Metallic Biomaterials ); Application ( Orthopedic, Cardiovascular, Dental, Ophthalmology, Tissue Engineering, Other ) and Geography

Primary Cell Culture Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Primary Cells, Reagents and Supplements, Media); Application (Tissue Culture And Tissue Engineering, Vaccine Production, Gene Therapy and Regenerative Medicine, Toxicity Testing and Drug Screening, Cancer Research, Others); Separation And Culture Techniques (Explant Method, Enzymatic Disaggregation, Mechanical Separation, Others) and Geography

Medical Biomimetics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ( Cardiovascular, Orthopedic, Ophthalmology, Dental, Others ); Application ( Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery, Others )

Bipolar Soft Tissue Dissection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Reusable, Disposable); End user (Hospital, Ambulatory Surgical Center, Specialty Clinic, Others) and Geography

Artificial Tissue Heart Valve Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Transcatheter Heart Valve, Surgical Heart Valve); Application (Aortic Stenosis, Aortic Regurgitation, Others) and Geography

Monopolar Soft Tissue Dissection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Reusable, Disposable); End user (Hospital, Ambulatory Surgical Center, Specialty Clinic, Others) and Geography

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/tissue-engineering-market

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg